Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 3147

1.

Organ-Organ Crosstalk and Alcoholic Liver Disease.

Poole LG, Dolin CE, Arteel GE.

Biomolecules. 2017 Aug 16;7(3). pii: E62. doi: 10.3390/biom7030062. Review.

2.

Hepatitis C Virus-Induced Autophagy and Host Innate Immune Response.

Chan ST, Ou JJ.

Viruses. 2017 Aug 12;9(8). pii: E224. doi: 10.3390/v9080224. Review.

3.

Imaging Features of Non-Alcoholic Fatty Liver Disease in Children and Adolescents.

Di Martino M, Koryukova K, Bezzi M, Catalano C.

Children (Basel). 2017 Aug 11;4(8). pii: E73. doi: 10.3390/children4080073. Review.

4.

Genomic testing as a tool to optimise drug therapy.

Somogyi AA, Phillips E.

Aust Prescr. 2017 Jun;40(3):101-104. doi: 10.18773/austprescr.2017.027. Epub 2017 Jun 1. Review. No abstract available.

5.

Structures and Corresponding Functions of Five Types of Picornaviral 2A Proteins.

Yang X, Cheng A, Wang M, Jia R, Sun K, Pan K, Yang Q, Wu Y, Zhu D, Chen S, Liu M, Zhao XX, Chen X.

Front Microbiol. 2017 Jul 21;8:1373. doi: 10.3389/fmicb.2017.01373. eCollection 2017. Review.

6.

Prognostic significance of red blood cell distribution width in gastrointestinal disorders.

Goyal H, Lippi G, Gjymishka A, John B, Chhabra R, May E.

World J Gastroenterol. 2017 Jul 21;23(27):4879-4891. doi: 10.3748/wjg.v23.i27.4879. Review.

7.

Elimination of HCV as a public health concern among people who inject drugs by 2030 - What will it take to get there?

Grebely J, Dore GJ, Morin S, Rockstroh JK, Klein MB.

J Int AIDS Soc. 2017 Jul 28;20(1):1-8. doi: 10.7448/IAS.20.1.22146. Review.

8.

Chronic hepatitis C virus infection: a new modifiable cardio-metabolic risk factor?

Cuciureanu T, Chiriac S, Chiorescu M, Gîrleanu I, Trifan A.

Clujul Med. 2017;90(3):251-255. doi: 10.15386/cjmed-793. Epub 2017 Jul 15. Review.

9.

Current status of hepatitis C virus infection and countermeasures in South Korea.

Jeong SH, Jang ES, Choi HY, Kim KA, Chung W, Ki M.

Epidemiol Health. 2017 Apr 13;39:e2017017. doi: 10.4178/epih.e2017017. eCollection 2017. Review.

10.

Phased implementation of spaced clinic visits for stable HIV-positive patients in Rwanda to support Treat All.

Nsanzimana S, Remera E, Ribakare M, Burns T, Dludlu S, Mills EJ, Condo J, Bucher HC, Ford N.

J Int AIDS Soc. 2017 Jul 21;20(Suppl 4):21-27. doi: 10.7448/IAS.20.5.21635. Review.

12.

Gut-Liver Axis Derangement in Non-Alcoholic Fatty Liver Disease.

Poeta M, Pierri L, Vajro P.

Children (Basel). 2017 Aug 2;4(8). pii: E66. doi: 10.3390/children4080066. Review.

13.

The Helminths Causing Surgical or Endoscopic Abdominal Intervention: A Review Article.

Uysal E, Dokur M.

Iran J Parasitol. 2017 Apr-Jun;12(2):156-168. Review.

14.

Association between HLA-DQ Gene Polymorphisms and HBV-Related Hepatocellular Carcinoma.

Lv J, Xu T, Qian Z, Wang H.

Gastroenterol Res Pract. 2017;2017:7150386. doi: 10.1155/2017/7150386. Epub 2017 Jul 6. Review.

15.

Prognostic value of red blood cell distribution width in hepatocellular carcinoma.

Goyal H, Hu ZD.

Ann Transl Med. 2017 Jul;5(13):271. doi: 10.21037/atm.2017.06.30. Review.

16.

Towards an evidence based approach for the development of adjuvanted vaccines.

O'Hagan DT, Friedland LR, Hanon E, Didierlaurent AM.

Curr Opin Immunol. 2017 Jul 26;47:93-102. doi: 10.1016/j.coi.2017.07.010. [Epub ahead of print] Review.

17.

Applicability of Metal Nanoparticles in the Detection and Monitoring of Hepatitis B Virus Infection.

Shevtsov M, Zhao L, Protzer U, Klundert MAAV.

Viruses. 2017 Jul 21;9(7). pii: E193. doi: 10.3390/v9070193. Review.

18.

The importance of immunization in cancer prevention, treatment, and survivorship.

Ward EM, Flowers CR, Gansler T, Omer SB, Bednarczyk RA.

CA Cancer J Clin. 2017 Jul 28. doi: 10.3322/caac.21407. [Epub ahead of print] Review.

19.

Advances in ultrasound-targeted microbubble-mediated gene therapy for liver fibrosis.

Huang C, Zhang H, Bai R.

Acta Pharm Sin B. 2017 Jul;7(4):447-452. doi: 10.1016/j.apsb.2017.02.004. Epub 2017 Mar 15. Review.

20.

Unsolved Puzzles Surrounding HCV Immunity: Heterologous Immunity Adds Another Dimension.

Agrawal B, Singh S, Gupta N, Li W, Vedi S, Kumar R.

Int J Mol Sci. 2017 Jul 27;18(8). pii: E1626. doi: 10.3390/ijms18081626. Review.

Supplemental Content

Loading ...
Support Center